Rapid molecular testing for clinical diagnostics
Abacus Diagnostica’s proprietary, fully automated testing platform GenomEra® CDX takes molecular testing to a new level of easiness and speed without compromising the quality of results.
Cost efficient automated solution
All-in-one PCR and RT-PCR test chips with homogeneous detection in fully automated instrument.
Reducing the costs by affordable pricing, robust assays and long service intervals.
CE IVD tests for infectious diseases
Critical human pathogens and antibiotic resistance markers such as C. difficile, Norovirus and MRSA
Our products
GenomEra CDX system has proven to be one of the fastest, easiest-to-use and the most cost-effective automated solution for molecular diagnostics (MDx) of infectious diseases. GenomEra is suitable also for small to mid-size customers without any prior experience in MDx.
News
-
Open position: QA/RA Director / Avoin työpaikka: Laatu- ja regulaatiojohtaja
We are looking for a QA/RA Director. Position requires fluent Finnish.
Toimintamme voimakkaasti kasvaessa etsimme joukkoomme laatu- ja regulaatiojohtajaa.
Työpaikkailmoitus -
New assay for rapid detection of SARS-CoV-2 variant strains now available for research use!
Abacus Diagnostica has developed a SARS-CoV-2 Variants of Concern (VoC) Assay for the GenomEra® CDX platform. In addition to detecting all SARS-CoV-2 strains, the new test detects clinically significant deletions present in the variants first identified in the UK (B.1.1.7), South Africa (B.1.351), and Brazil (P.1). The test is now available as a Research Use Only -product.
-
GenomEra® multiplex assay is now CE marked and available!
For inquiries, please contact info@abacusdiagnostica.com